| Literature DB >> 8859212 |
Abstract
A proton pump inhibitor is the most cost-effective choice for severe disease and, in low doses, for moderate disease. Patients with mild disease and infrequent relapses can be managed with a H2-receptor antagonist, an antacid, or cisapride.Entities:
Mesh:
Substances:
Year: 1996 PMID: 8859212 DOI: 10.1080/21548331.1996.11443366
Source DB: PubMed Journal: Hosp Pract (1995) ISSN: 2154-8331